Baudax Bio’s ANJESO® Achieves Formulary Listing at Over 100 Institutions in Less Than One Year on the Market Jun 08, 2021 7:00am EDT
Baudax Bio Announces the Cancellation of Adjourned Portion of Annual Shareholder Meeting May 28, 2021 4:05pm EDT
Baudax Bio Announces Publication of Phase IIIb ANJESO® Data in the Journal Pain Management May 17, 2021 7:00am EDT
Leading Independent Advisory Firm Institutional Shareholder Services, Inc. Recommends Baudax Bio Shareholders Vote "For" the Proposed Additional Authorized Shares May 13, 2021 7:00am EDT
Leading Independent Proxy Advisory Firm Glass Lewis & Co. Recommends Baudax Bio Shareholders Vote "For" The Additional Authorized Shares May 12, 2021 9:02am EDT
Baudax Bio to Report First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 5, 2021 Apr 29, 2021 7:00am EDT
